KMH Labs
- Company typePrivate
- Founded1988
- HeadquartersMississauga, Canada
- Headcount251–500
- GTM typeB2B and B2C
- OfferingServices
KMH Labs firmographics
Firmographics- Name
- KMH Labs
- Legal name
- KMH Cardiology Centres Inc.
- Website
- https://www.kmhlabs.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
KMH Labs industry classification
Industry- Product category
- Cardiac Diagnostic Services
- NAICS
- Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)
- akta.pro secondary industries
- Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
Keywords
Where KMH Labs is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices10 records
Markets served
KMH Labs business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- OHIP-Funded Diagnostic Services: Most diagnostic and specialist services are covered by the Ontario Health Insurance Plan (OHIP). Patients with valid Ontario health cards incur no out-of-pocket cost for covered services. This is the primary revenue stream.
- Uninsured/Private Pay Services: Patients without OHIP coverage or third-party billing pay out-of-pocket for services. Comprehensive fee schedules exist for consultations, cardiac diagnostics, Holter monitoring, MRI, and PET/CT scans. Weekend rates carry a premium. ABPM is not covered by OHIP.
- PET/CT Private Pay: PET/CT scans available for patients not eligible for OHIP-funded scans or who choose to pay privately. Requires completed PET requisition and supporting documentation.
- ABPM (Ambulatory Blood Pressure Monitoring): ABPM is not covered by OHIP. Standalone fee of $85 for one day or $170 for two days, charged directly to the patient.
- Clinical Research & Trials: KMH conducts clinical trials and research in partnership with pharmaceutical companies. Research partnerships with major pharmaceutical firms (AbbVie, AstraZeneca, Pfizer, Roche, etc.) generate revenue through trial site fees and imaging services for drug development.
- PocketHealth Membership Plans: PocketHealth offers free and paid membership plans for patients to access and share their medical imaging records. Revenue shared between PocketHealth and KMH for records management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | First Consultation - $488 weekday, $688 weekend |
| Unit Pricing | Pay-as-you-go | Cardiac Diagnostics - $34 to $1,452 depending on test type |
| Unit Pricing | Pay-as-you-go | Holter Monitoring - $312 to $1,261 depending on duration |
| Unit Pricing | Pay-as-you-go | MRI - $1,810 to $4,190 depending on body parts and contrast |
| Unit Pricing | Pay-as-you-go | PET/CT - $2,630 to $4,380 depending on scan type |
| Unit Pricing | Pay-as-you-go | Administrative Fees - $30 to $150 |
| Freemium | Monthly | PocketHealth Free and Paid Membership Plans |
| Unit Pricing | Pay-as-you-go | ABPM - $85 for one day, $170 for two days (not covered by OHIP) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels8 records
KMH Labs product offering
Product offeringCore offering
KMH Labs operates a multi-modality cardiac diagnostic platform across 11 locations in the Greater Toronto Area and Southwestern Ontario, providing specialist cardiology and internal medicine consultations, MRI, PET/CT, nuclear medicine, echocardiography, stress testing, and Holter monitoring. The platform is augmented with proprietary AI-powered clinical and administrative tools (AI Scribe, AI Intake & Triage, AI Fax & Referral Intelligence), a real-time Practice Pulse performance dashboard, and integration with GE Healthcare imaging platforms and the PocketHealth patient portal. KMH also conducts clinical research in partnership with pharmaceutical companies and operates the Cardiac Athlete Screening Program (CASP), the only professional athlete cardiac screening program in Canada.
Product overview
KMH Labs operates as a multi-modality cardiac diagnostic platform offering a unified portfolio of diagnostic services across 11 locations in the Greater Toronto Area and Southwestern Ontario. The core offering consists of Specialist Consultations (cardiology and internal medicine), MRI imaging, Cardiology & Nuclear Medicine diagnostics, PET/CT scanning, and Research clinical trials. Supporting these are diagnostic sub-services including Echocardiography, Stress Echocardiography, Graded Exercise Tests, Resting ECG, Holter Monitoring, Nuclear Cardiology/Myocardial Perfusion Imaging, and specialized PET/CT modalities (FDG and PSMA). The platform layer includes Practice Pulse Dashboard for physician performance metrics, AI Clinical Tools (AI Scribe and AI Intake & Triage) for documentation and pre-visit assessment, AI Fax & Referral Intelligence for automated referral processing, and PocketHealth integration for patient and physician access to imaging records. The company also offers the Cardiac Athlete Screening Program (CASP) as a specialized screening service for professional and amateur athletes.
Differentiator
Problem solved
Functional benefit
Products and services
- Specialist Consult Expert cardiology and internal medicine specialist consultations offered in-person and virtually across Ontario for patients referred by healthcare providers.
- MRI (Magnetic Resonance Imaging) Non-invasive cardiac and body MRI imaging including neuroimaging, musculoskeletal, abdomen/pelvis, breast imaging, MRA/MRV, MR arthrography, and MR enterography, available at the Kitchener and Markham centres.
- Cardiology & Nuclear Medicine Complete cardiovascular diagnostics including ECG, Holter monitoring (24h–14 days), echocardiography, stress echocardiography, graded exercise stress testing, and nuclear cardiology such as Myocardial Perfusion Imaging and MUGA scans, available across all GTA locations.
- PET/CT Positron emission tomography combined with CT for cardiac viability evaluation and oncology indications including FDG, PSMA (prostate), and amyloid (dementia) imaging, available at the Mississauga West centre.
- Research (Clinical Trials) Clinical trials and research conducted in partnership with major pharmaceutical companies (AbbVie, AstraZeneca, Pfizer, Roche, etc.) across cardiology, neurology, oncology, metabolic, gastroenterology, and rheumatology.
- Cardiac Athlete Screening Program (CASP) Comprehensive cardiovascular screening program for professional and amateur athletes to detect hidden heart conditions and ensure safe sports participation.
Quantifiable outcome
- Net Promoter Score of 86 across all patient consultations
- +6 more outcomes
Companies that use KMH Labs
Customer profileNamed customers10 records
Ideal customer profiles5 records
KMH Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature5 records
KMH Labs partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core and minor.
- GE HealthcarecoreState-of-the-art imaging platforms powering clinical research capabilities. Over 15 years of longitudinal medical data spanning cardiac disease, variant cancers, and ambulatory monitoring, leveraged through the GE Healthcare partnership. Powers 50+ clinical studies across oncology, cardiology, and neurology.
- AbbVieminorPharmaceutical partner participating in clinical research trials at KMH. Listed among pharmaceutical partners on the research page.
- AlnylamminorPharmaceutical partner participating in clinical research trials at KMH. Listed among pharmaceutical partners on the research page.
- AmgenminorPharmaceutical partner participating in clinical research trials at KMH.
- AnavexminorPharmaceutical partner participating in clinical research trials at KMH in neurology (Alzheimer's disease) area.
- AstraZenecaminorPharmaceutical partner participating in clinical research trials at KMH.
- BiogenminorPharmaceutical partner participating in clinical research trials at KMH, particularly in neurology.
- Boehringer IngelheimminorPharmaceutical partner participating in clinical research trials at KMH.
- EisaiminorPharmaceutical partner participating in clinical research trials at KMH, particularly in Alzheimer's disease.
- Eli LillyminorPharmaceutical partner participating in clinical research trials at KMH.
- GenentechminorPharmaceutical partner participating in clinical research trials at KMH.
- JanssenminorPharmaceutical partner participating in clinical research trials at KMH.
- MerckminorPharmaceutical partner participating in clinical research trials at KMH.
- NovartisminorPharmaceutical partner participating in clinical research trials at KMH.
- PfizerminorPharmaceutical partner participating in clinical research trials at KMH.
- RocheminorPharmaceutical partner participating in clinical research trials at KMH.
- SanofiminorPharmaceutical partner participating in clinical research trials at KMH.
- PocketHealthcoreSecure online platform enabling patients to view, download, and share their KMH imaging records. Referring physicians can access patient imaging directly through PocketHealth's web viewer. KMH is integrated with PocketHealth for both patient enrollment and physician access workflows.
- Ontario Health (OCINet)coreKMH participates in the Ontario Clinical Imaging Network (OCINet), an independent not-for-profit corporation and delivery partner of Ontario Health. OCINet systems store and provide access to clinical imaging information within diagnostic imaging repositories (DIRs), accessible to authorized healthcare providers across the province for continuity of care.
Scale indicators11 records
Recent moves6 records
Expansion highlights5 records
KMH Labs competitors and assessment
Company assessmentDirect peers
- LifeLabs: Canada's largest medical laboratory and diagnostics provider, offering a broad multi-modality testing footprint across provinces. Comparable to KMH as a large-scale Canadian outpatient diagnostics platform serving both physician referrals and self-pay patients.
- Dynacare: Major Canadian clinical laboratory and diagnostics operator with extensive physician referral channels across Ontario and Western Canada. Comparable to KMH in operating multi-modality outpatient diagnostics with strong physician relationships.
- MCI Onehealth: Canadian outpatient healthcare network combining physician practice, diagnostics, and specialty services with technology-enabled workflows. Comparable to KMH in delivering integrated specialist consultations and diagnostic imaging under one platform across Ontario.
- Sentrex Health Solutions: Canadian specialty cardiology distribution and services company serving cardiology clinics and referring physicians across Canada. Comparable to KMH in its Canadian cardiology-centric commercial focus and physician relationship model.
- True North Imaging: Canadian outpatient diagnostic imaging provider offering MRI, CT, ultrasound, and X-ray services with multiple Ontario locations. Comparable to KMH as an Ontario-based multi-site imaging operator competing for the same referring physician base.
- Medcan: Toronto-based preventive health, diagnostics, and executive medicine clinic offering advanced cardiac screening, MRI, and specialist consultations. Comparable to KMH in combining multi-modality diagnostics, specialist consults, and a strong Toronto physician referral network.
Emerging players
- HeartFlow: US-based cardiac diagnostics company using AI-enabled FFR-CT analysis to non-invasively assess coronary artery disease. Comparable to KMH as an emerging technology-led cardiac diagnostic competitor that could shift guideline-driven demand away from traditional imaging.
- Cleerly: AI-driven coronary plaque analysis platform for cardiac disease detection and risk stratification. Comparable to KMH as a technology-first cardiac diagnostic competitor that competes for the same referring cardiologist mindshare.
- iRhythm Technologies: Digital cardiac monitoring company offering the Zio patch for long-duration continuous ECG monitoring. Comparable to KMH's Holter monitoring franchise as an AI-enabled alternative for ambulatory cardiac rhythm assessment.
Broad incumbents
- Cleveland Clinic: US-based multi-specialty academic health system with a leading cardiovascular institute offering comprehensive diagnostics, imaging, and specialty care. Comparable to KMH as a benchmark for clinical excellence, brand reputation, and complex multi-modality cardiac diagnostic delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
KMH Labs social profiles
Digital presenceKMH Labs compliance and trust
Trust signalCompliance1 record
KMH Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
KMH Labs leadership team
Management profileNumber of profiles
Profiles7 records
KMH Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KMH Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KMH Labs
What does KMH Labs do?
KMH Labs operates a multi-modality cardiac diagnostic platform across 11 locations in the Greater Toronto Area and Southwestern Ontario, providing specialist cardiology and internal medicine consultations, MRI, PET/CT, nuclear medicine, echocardiography, stress testing, and Holter monitoring. The platform is augmented with proprietary AI-powered clinical and administrative tools (AI Scribe, AI Intake & Triage, AI Fax & Referral Intelligence), a real-time Practice Pulse performance dashboard, and integration with GE Healthcare imaging platforms and the PocketHealth patient portal. KMH also conducts clinical research in partnership with pharmaceutical companies and operates the Cardiac Athlete Screening Program (CASP), the only professional athlete cardiac screening program in Canada.
Is KMH Labs a public or private company?
KMH Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KMH Labs founded?
KMH Labs was founded in 1988. It employs 251 to 500 people.
Where is KMH Labs based?
KMH Labs is headquartered in Mississauga, Canada, in the North America region.
How does KMH Labs make money?
Six revenue lines are on record. OHIP-Funded Diagnostic Services are the primary driver. The others are uninsured/Private Pay Services, PET/CT Private Pay, ABPM (Ambulatory Blood Pressure Monitoring), clinical Research & Trials and pocketHealth Membership Plans.
Who are KMH Labs's main competitors?
Direct peers on record are LifeLabs, Dynacare, MCI Onehealth, Sentrex Health Solutions, True North Imaging and Medcan. Emerging players are HeartFlow, Cleerly and iRhythm Technologies. Cleveland Clinic is listed as a broad incumbent.
Does KMH Labs have an API?
No public API is recorded for KMH Labs.
What industry is KMH Labs in?
KMH Labs's product category is Cardiac Diagnostic Services. Its primary akta.pro industry code is HLAFAKAE, Cardiac Diagnostic Centers (Echo/Stress Testing/Holter), with a secondary code of HLAKABAE, Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear). Its NAICS code is 621512 and its SIC code is 8000.